Tibet Rhodiola Pharmaceutical Holding Co. Class ASSE: 600211

Announcement on Obtaining Approval for Drug Supplement Application for Imdur (Chinese Market)

· Issued by Tibet Rhodiola Pharmaceutical Holding Co. Class A via Shanghai Stock Exchange
Announcement on Obtaining Approval for Drug Supplement Application for Imdur (Chinese Market)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment